ClinicalTrials.gg
RecruitingNCT05488054Updated Dec 24, 2025

Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery

An interventional study of Physical Therapy and Monitored Work-out in ACL Injury and Hip Injuries, sponsored by University Hospitals Cleveland Medical Center. Recruiting at 2 sites in United States. Open to participants aged 14 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-24.

Sponsored by University Hospitals Cleveland Medical Center · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Aug 2022; still recruiting 4 years 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
226
Allocation
Non-randomized
Ages
14 Years to 30 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 176 studies in Anterior Cruciate Ligament Injuries with a site in United States — 44 open to participants now, 62 under way, 3 of them phase 3. Anterior Cruciate Ligament Injuries · United States.

Planned enrollment
10th of 152
226 · median 50
Started
2022
with 18 others
No phase
113 of 176
27 open now
Primary completion
2026-12
later than 21 of 61 live
Registered
124th of 176
by date

Among the 176 studies in Anterior Cruciate Ligament Injuries with a site in United States, this one is the 10th largest by planned enrollment of the 152 interventional ones that give a count, is one of 19 that started in 2022, is one of 113 with no phase, reaches primary completion later than 21 of the 61 other live ones, and was the 124th registered.

Anterior Cruciate Ligament Injuries

627 studies on the registry are indexed under Anterior Cruciate Ligament Injuries; 193 are open to participants now.

Browse Anterior Cruciate Ligament Injuries studies →

Open to participants now

44 of the 176 studies in Anterior Cruciate Ligament Injuries with a site in United States are open now. Recruiting first, the newest first:

39 more — sign in →

All 44 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 122 Anterior Cruciate Ligament Injuries studies recruiting now, 27 (22%) set no upper age limit and 92 (75%) stop at 75 or younger; 46 take children under 18; 21 take healthy volunteers.

This study: 14 Years to 30 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 176 studies in Anterior Cruciate Ligament Injuries with a site in United States, or all of them as a file.
02

Study summary

This study will utilize the Moxy wearable sensor to measure muscle oxygen saturation levels in athletes following lower extremity surgery (ACL or Hip arthroscopy) to evaluate their Return-to-Play. The acquired data will complement current protocols utilized by Dr. Voos and Dr. Salata in this regard and will add quantifiable evidence to enable a robust measurement of the surgical limb versus non-surgical limb.

Read the detailed description

Patients with a diagnosis of ACL tear or hip pathology will undergo surgery. Following surgery, patients will report to clinic for scheduled physical therapy per their institution's injury-specific physical therapy protocol. At set time points (6-week, 12-week, 6 months, and 9 months) during their recovery, patients will be assessed for muscle oxygen saturation and hemoglobin levels with the Moxy sensor. This sensor is a non-invasive device placed over the rectus femoris to monitor oxygen and hemoglobin levels. The patient will then follow the therapy as instructed by the physical therapist and perform the protocol-specific exercises with the sensor in place. The measured parameters will be recorded and stored per patient.

The injured patients will be compared to healthy control patients undergoing a similar one-hour exercise session while wearing the Moxy sensor for comparison of results.

The goal of this study is to use the data obtained from the Moxy sensor device to further predict recovery of function in muscles supporting injured soft tissues to determine safe return to sport.

03

Conditions studied

  • ACL Injury
  • Hip Injuries
04

Who can participate

Ages eligible
14 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age range: Patients age 14 to 30 years
  • Patients with ACL injury requiring surgical correction
  • Patients undergoing arthroscopic hip surgery
  • Healthy individuals with no history of ACL, arthroscopic knee or arthroscopic hip surgery

Exclusion criteria

Exclusion Criteria:

  • Patients below 14 years or above 30 years
  • Non-English-speaking subjects
  • Pregnant individuals
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
226 participants (estimated)

Study arms

  • Experimental
    Healthy Individuals

    Healthy control patients with no history of knee or hip surgery for comparison of baseline values

    Procedure: Monitored Work-out · Device: Moxy Oxygen Sensor Device

  • Experimental
    Surgical Patients

    Patients who have undergone arthroscopic ACL surgery or arthroscopic hip surgery and are undergoing physical therapy for return to sport

    Procedure: Physical Therapy · Device: Moxy Oxygen Sensor Device

Interventions

  • ProcedurePhysical Therapy

    Patients will undergo physical therapy following surgical intervention

  • ProcedureMonitored Work-out

    Healthy volunteers will undergo a monitored workout for comparison of data

  • DeviceMoxy Oxygen Sensor Device

    Individuals will wear a Moxy sensor device during workouts to monitor oxygen and hemoglobin levels in their muscles

06

What researchers measure

Primary outcomes

  1. Change in O2 Saturation levels as measured by Moxy Sensor device

    Time frame: 6 months, 9 months, 12 months (once for healthy individuals)

  2. Changes in hemoglobin levels as measured by Moxy Sensor device

    Time frame: 6 months, 9 months, 12 months (once for healthy individuals)

07

Study locations

1 of 2 sites recruiting
  • University Hospitals Physical Therapy
    Avon, Ohio 44011, United States
    Not yet recruiting
    • Benjamin Geletka, PT · Contact440-988-6890
  • University Hospitals Cleveland Medial Center
    Cleveland, Ohio 44106, United States
    Recruiting
    • James Voos, MD · Contact216-844-0209
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2022 (actual). Primary completion is estimated for Dec 2026, 52 months after the start.

Of 279 non-industry interventional studies with no phase under Anterior Cruciate Ligament Injuries, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 70. This study's planned 52 months is above that.

Counting every sponsor, half of 288 studies reached it within 30 months; a quarter within 14 and three quarters within 70.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 2, 2022
First posted
Aug 4, 2022
StartActual
Aug 8, 2022
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Dec 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05488054
Responsible party
James E Voos, MD (Chairman, Department of Orthopaedic Surgery, University Hospitals Cleveland Medical Center) — Principal investigator
First posted
Aug 4, 2022
Start date
Aug 8, 2022
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Dec 24, 2025

Study contacts

James Voos, MD
Contact
james.voos@UHhospitals.org
216-844-0209
James Voos, MD
principal investigator · University Hospitals Cleveland Medical Center
Sunita Mengers, MD
study director · University Hospitals Cleveland Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion